...
首页> 外文期刊>Journal of pediatric gastroenterology and nutrition >Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition.
【24h】

Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition.

机译:用益生菌和/或益生元补充婴儿配方食品:ESPGHAN营养委员会的系统评价和评论。

获取原文
获取原文并翻译 | 示例

摘要

Infant formulae are increasingly supplemented with probiotics, prebiotics, or synbiotics despite uncertainties regarding their efficacy. The present article, developed by the Committee on Nutrition of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition, systematically reviews published evidence related to the safety and health effects of the administration of formulae supplemented with probiotics and/or prebiotics compared with unsupplemented formulae. Studies in which probiotics/prebiotics were not administered during the manufacturing process, but thereafter, for example in capsules, the contents of which were supplemented to infant formula or feeds, were excluded.On the basis of this review, available scientific data suggest that the administration of currently evaluated probiotic- and/or prebiotic-supplemented formula to healthy infants does not raise safety concerns with regard to growth and adverse effects. The safety and clinical effects of 1 product should not be extrapolated to other products. At present, there is insufficient data to recommend the routine use of probiotic- and/or prebiotic-supplemented formulae. The Committee considers that the supplementation of formula with probiotics and/or prebiotics is an important field of research. There is a need in this field for well-designed and carefully conducted randomised controlled trials, with relevant inclusion/exclusion criteria and adequate sample sizes. These studies should use validated clinical outcome measures to assess the effects of probiotic and/or prebiotic supplementation of formulae. Such trials should also define the optimal doses and intake durations, as well as provide more information about the long-term safety of probiotics and/or prebiotics. Because most of the trials were company funded, independent trials, preferentially financed jointly by national/governmental/European Union bodies and other international organisations, would be desirable.
机译:尽管婴儿配方奶粉的功效尚不确定,但它们越来越多地添加了益生菌,益生元或合生元。由欧洲小儿胃肠病学,肝病学和营养学协会营养委员会开发的本文系统地回顾了已发表的证据,这些证据与与未补充配方的益生菌和/或益生元相配合的配方的安全性和健康影响有关。在生产过程中未施用益生菌/益生元,但随后例如以胶囊形式添加到婴儿配方食品或饲料中的胶囊的研究被排除在外。对健康的婴儿服用目前评估过的益生菌和/或益生元补充配方食品不会增加对生长和不良反应的安全性关注。 1种产品的安全性和临床效果不应外推到其他产品。目前,没有足够的数据推荐常规使用益生菌和/或益生元补充配方。委员会认为,用益生菌和/或益生元补充配方食品是一个重要的研究领域。在该领域中,需要精心设计和精心进行的随机对照试验,并采用相关的纳入/排除标准和足够的样本量。这些研究应使用经过验证的临床结果指标来评估益生菌和/或益生元补充配方食品的效果。此类试验还应确定最佳剂量和摄入持续时间,并提供有关益生菌和/或益生元的长期安全性的更多信息。由于大多数试验是公司资助的,因此最好由国家/政府/欧盟机构和其他国际组织共同资助的独立试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号